XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net income (loss) $ (3,170,176) $ (976,673)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 126,753 41,637
Stock compensation 467,517 677,507
Bad debt expense 49,659 0
Change in fair value of contingent consideration (341,983) 0
Amortization of debt discount 452,865 0
Gain on expiration of accrued tax liability (53,266) 0
Changes in operating assets and liabilities:    
Accounts receivable 278,181 (3,973,740)
Other receivables (263,646) 5,557
Inventories (22,700) (270,687)
Prepaid expenses and other current assets 156,307 (26,515)
Long-term receivables 9,225 0
Accounts payable (236,432) (140,754)
Long-term payables (37,695) 0
Accounts payable and accrued liabilities - related parties 5,849 500,597
Accrued liabilities 1,360,199 711,573
Accrued payroll taxes, penalties and interest 35,242 23,690
Deferred revenue (24,700) 249,526
Right of use assets and liabilities, net 1,125 (34,438)
Net cash used in operating activities (1,207,676) (3,212,720)
Cash flows from investing activities:    
Purchase of property and equipment (341,538) (122,871)
Purchase of intangibles (88,000) (95,000)
Net cash used in investing activities (429,538) (217,871)
Cash flows from financing activities:    
Proceeds from related party notes payable 3,680,279 3,399,035
Repayments of related party notes payable (752,256) 0
Net proceeds (repayments) from notes payable (46,239) (10,911)
Repayments of convertible note payable (240,000) 0
Repurchase of common shares from subsidiary 0 (14,826)
Net cash provided by financing activities 2,641,784 3,373,298
Net change in cash and cash equivalents 1,004,570 (57,293)
Effect of exchange rate changes on cash 63,762 39,344
Cash, cash equivalents, and restricted cash at beginning of period 772,062 110,285
Cash, cash equivalents, and restricted cash at end of period 1,840,394 92,336
Supplemental disclosure of cash flow information:    
Cash paid for interest 29,766 0
Supplemental disclosure of non-cash investing and financing activities:    
Conversion of related party notes and interest into preferred stock 0 6,532,206
Contribution of property and equipment into joint venture 0 111,185
Issuance of shares to joint venture partner 0 58,560
Conversion of convertible note payable, accrued interest and premium into common stock 1,111,397 0
Increase in right of use asset and liability $ 1,318,284 $ 0